GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biosynex ALBIO.PA · EUR

Health Care · Euronext Paris · 🇫🇷 France

Compare

0.82

-1.45%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Biosynex — daily ALBIO

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Biosynex on TradingView ↗
Market value
€15.3m
Last close × shares
Volume
1.5k
Shares, 9 Nov 2026

About Biosynex

Its shares trade on Euronext Paris under the ticker ALBIO.PA. It has been listed since 21 March 2011. In the fiscal year to 31 December 2025, it reported revenue of €95.2m and a net loss of €58.2m. At that date it held total assets of €136.2m and shareholders' equity of €32.4m.

Biosynex SA engages in the development of practical diagnostics in order to prevent, diagnose and enable appropriate patient care management. The company is headquartered in Illkirch-Graffenstaden, Grand Est. The company went IPO on 2011-03-21. The Company’s products are used by biological and analytical services laboratories, obstetric units and emergency units, as well as in medical resource-limited settings. Biosynex SA specializes in four fields: tropical diseases, emergency markers, infectious diseases and autoimmunity. The Company’s products include Amnioquick (Obstetrics); Immunoquick Malaria Falciparum and Immunoquick Malaria +4 (Parasitology); Immunoquick Elifa HSV IGG, Immunoquick Elifa EBV G and Immunoquick Mono (Virology); Immunoquick Filtration CELIAC IgA and Immunoquick TG (Autoimmunology); and Immunoquick Tetanus (Bacteriology). The company operates through Fumouze Diagnostics and SR2B.

Figures and description from our data supplier, not checked against the company's own report.

More about Biosynex →

Latest on Biosynex

Our reporting

We have not reported on Biosynex yet.

Next results

3 Mar 2027

Due on 3 Mar 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Biosynex's ticker?

Biosynex trades as ALBIO.PA on Euronext Paris, under ISIN FR0011005933.

What was Biosynex's last closing price?

0.82 on 9 Nov 2026. The figure is in EUR and is never converted.

When does Biosynex next report results?

Results are expected on 3 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.